The proportion of patients treated for invasive carcinoma or an advanced stage of the disease have both leapt in recent years, experts wrote in Clinical Imaging. 

The ratings agency first issued its downgrade in July, citing the risk of prolonged business impact from COVID-19 and uncertainty around radiology's future. 

The move comes after the Senate recently passed a fix to address the 2% Medicare sequester reduction set to take hold April 1. 

Growing imaging workloads and clear patient benefits should encourage rads to see this as an opportunity rather than a turf threat, two experts argued in a new editorial.

“One year into the COVID-19 pandemic, we already see the consequences of pandemic-driven drops in cancer screening and diagnostics," ASTRO Chair Thomas Eichler, MD, said.

The FDA is alerting patients who have received breast imaging services from Tennessee Women’s Care amid concerns about its safety practices. 

As part of the change, the El Segundo, California-based imaging giant promoted 13 of its top physicians to serve in new leadership roles. 

Increases held steady over the past decade, but leapt during the height of the COVID-19 crisis in 2020, the American Medical Association reported.